144 related articles for article (PubMed ID: 11874201)
61. Transplantation of Neural Progenitor Cells Expressing Glial Cell Line-Derived Neurotrophic Factor into the Motor Cortex as a Strategy to Treat Amyotrophic Lateral Sclerosis.
Thomsen GM; Avalos P; Ma AA; Alkaslasi M; Cho N; Wyss L; Vit JP; Godoy M; Suezaki P; Shelest O; Bankiewicz KS; Svendsen CN
Stem Cells; 2018 Jul; 36(7):1122-1131. PubMed ID: 29656478
[TBL] [Abstract][Full Text] [Related]
62. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways.
Ayers JI; Fromholt SE; O'Neal VM; Diamond JH; Borchelt DR
Acta Neuropathol; 2016 Jan; 131(1):103-14. PubMed ID: 26650262
[TBL] [Abstract][Full Text] [Related]
63. An oligomer-specific antibody improved motor function and attenuated neuropathology in the SOD1-G93A transgenic mouse model of ALS.
Dong QX; Zhu J; Liu SY; Yu XL; Liu RT
Int Immunopharmacol; 2018 Dec; 65():413-421. PubMed ID: 30388515
[TBL] [Abstract][Full Text] [Related]
64. Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse.
Naveilhan P; ElShamy WM; Ernfors P
Eur J Neurosci; 1997 Jul; 9(7):1450-60. PubMed ID: 9240402
[TBL] [Abstract][Full Text] [Related]
65. Prolonged survival and milder impairment of motor function in the SOD1 ALS mouse model devoid of fibroblast growth factor 2.
Thau N; Jungnickel J; Knippenberg S; Ratzka A; Dengler R; Petri S; Grothe C
Neurobiol Dis; 2012 Aug; 47(2):248-57. PubMed ID: 22542539
[TBL] [Abstract][Full Text] [Related]
66. Glial cell line-derived neurotrophic factor (GDNF), a new neurotrophic factor for motoneurones.
Zurn AD; Baetge EE; Hammang JP; Tan SA; Aebischer P
Neuroreport; 1994 Dec; 6(1):113-8. PubMed ID: 7703397
[TBL] [Abstract][Full Text] [Related]
67. Characterization of chronic glutamate-mediated motor neuron toxicity in organotypic spinal cord culture prepared from ALS model mice.
Kosuge Y; Sekikawa-Nishida K; Negi H; Ishige K; Ito Y
Neurosci Lett; 2009 Apr; 454(2):165-9. PubMed ID: 19429077
[TBL] [Abstract][Full Text] [Related]
68. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons.
Yan Q; Matheson C; Lopez OT
Nature; 1995 Jan; 373(6512):341-4. PubMed ID: 7830768
[TBL] [Abstract][Full Text] [Related]
69. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
[TBL] [Abstract][Full Text] [Related]
70. Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transport.
Lu YY; Wang LJ; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
Neurosci Res; 2003 Jan; 45(1):33-40. PubMed ID: 12507722
[TBL] [Abstract][Full Text] [Related]
71. Expression of GDNF and GDNFR-alpha mRNAs in muscles of patients with motor neuron diseases.
Yamamoto M; Mitsuma N; Inukai A; Ito Y; Li M; Mitsuma T; Sobue G
Neurochem Res; 1999 Jun; 24(6):785-90. PubMed ID: 10447463
[TBL] [Abstract][Full Text] [Related]
72. Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Suzuki M; Svendsen CN
Methods Mol Biol; 2016; 1382():325-36. PubMed ID: 26611598
[TBL] [Abstract][Full Text] [Related]
73. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
74. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
75. Aggregates of mutant protein appear progressively in dendrites, in periaxonal processes of oligodendrocytes, and in neuronal and astrocytic perikarya of mice expressing the SOD1(G93A) mutation of familial amyotrophic lateral sclerosis.
Stieber A; Gonatas JO; Gonatas NK
J Neurol Sci; 2000 Aug; 177(2):114-23. PubMed ID: 10980307
[TBL] [Abstract][Full Text] [Related]
76. Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS.
Das MM; Svendsen CN
Neurobiol Aging; 2015 Feb; 36(2):1130-9. PubMed ID: 25443290
[TBL] [Abstract][Full Text] [Related]
77. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.
Mourelatos Z; Gonatas NK; Stieber A; Gurney ME; Dal Canto MC
Proc Natl Acad Sci U S A; 1996 May; 93(11):5472-7. PubMed ID: 8643599
[TBL] [Abstract][Full Text] [Related]
78. Early decrease of survival factors and DNA repair enzyme in spinal motor neurons of presymptomatic transgenic mice that express a mutant SOD1 gene.
Nagano I; Murakami T; Manabe Y; Abe K
Life Sci; 2002 Dec; 72(4-5):541-8. PubMed ID: 12467894
[TBL] [Abstract][Full Text] [Related]
79. [Experimental approach to the gene therapy of motor neuron disease with the use of genes hypoxia-inducible factors].
Ismailov ShM; Barykova IuA; Shmarov MM; Tarantul VZ; Barskov IV; Kucherianu VG; Brylev LV; Logunov DIu; Tutykhina IL; Bocharov EV; Zakharova MN; Naroditskiĭ BS; Illarioshkin SN
Genetika; 2014 May; 50(5):591-601. PubMed ID: 25715475
[TBL] [Abstract][Full Text] [Related]
80. Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS.
Lladó J; Haenggeli C; Pardo A; Wong V; Benson L; Coccia C; Rothstein JD; Shefner JM; Maragakis NJ
Neurobiol Dis; 2006 Jan; 21(1):110-8. PubMed ID: 16084734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
